Citations

Citations to this article as recorded by  

• Chidamide and orelabrutinib synergistically induce cell cycle arrest and apoptosis in diffuse large B-cell lymphoma by regulating the PI3K/AKT/mTOR pathway
  Chunyan Wu, Shilv Chen, Zhimin Wu, Jiao Xue, Wen Zhang, Shan Wang, Xindong Zhao, Shaoling Wu
  Journal of Cancer Research and Clinical Oncology.2024;[Epub]     CrossRef
• Targeting HDACs for diffuse large B-cell lymphoma therapy
  Chunyan Wu, Qiao Song, Sophie Gao, Shaoling Wu
  Scientific Reports.2024;[Epub]     CrossRef
• Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies
  Ailin Zhao, Hui Zhou, Jinrong Yang, Meng Li, Ting Niu
  Signal Transduction and Targeted Therapy.2023;[Epub]     CrossRef
• Understanding HAT1: A Comprehensive Review of Noncanonical Roles and Connection with Disease
  Miguel A. Ortega, Diego De Leon-Oliva, Cielo Garcia-Montero, Oscar Fraile-Martinez, Diego Liviu Boaru, María del Val Toledo Lobo, Ignacio García-Tuñón, Mar Royuela, Natalio García-Honduvilla, Julia Bujan, Luis G. Guijarro, Melchor Alvarez-Mon, Miguel Ánge
  Genes.2023; 14(4): 915.     CrossRef
• HAT1: Landscape of Biological Function and Role in Cancer
  Vincenza Capone, Laura Della Torre, Daniela Carannante, Mehrad Babaei, Lucia Altucci, Rosaria Benedetti, Vincenzo Carafa
  Cells.2023; 12(7): 1075.     CrossRef
• Recent advancement of HDAC inhibitors against breast cancer
  Syed Abdulla Mehmood, Kantrol Kumar Sahu, Sounok Sengupta, Sangh Partap, Rajshekhar Karpoormath, Brajesh Kumar, Deepak Kumar
  Medical Oncology.2023;[Epub]     CrossRef
• Noncoding rules of survival: epigenetic regulation of normal and malignant hematopoiesis
  LaShanale Wallace, Esther A. Obeng
  Frontiers in Molecular Biosciences.2023;[Epub]     CrossRef
• Potential Therapeutic Use of Aptamers against HAT1 in Lung Cancer
  José Ignacio Klett-Mingo, Celia Pinto-Díez, Julio Cambronero-Plaza, Rebeca Carrión-Marchante, Miriam Barragán-Usero, María Isabel Pérez-Morgado, Eulalia Rodríguez-Martín, Mª Val Toledo-Lobo, Víctor M González, M. Elena Martín
  Cancers.2022; 15(1): 227.     CrossRef
• Modulation of serine/threonine-protein phosphatase 1 (PP1) complexes: A promising approach in cancer treatment
  Bárbara Matos, John Howl, Carmen Jerónimo, Margarida Fardilha
  Drug Discovery Today.2021; 26(11): 2680.     CrossRef
• Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1/EZH2 complex in pancreatic cancer
  Yan Sun, Dianyun Ren, Yingke Zhou, Jian Shen, Heshui Wu, Xin Jin
  Cell Death & Disease.2021;[Epub]     CrossRef
• Deciphering genes associated with diffuse large B-cell lymphoma with lymphomatous effusions: A mutational accumulation scoring approach
  Sina Abdollahi, Seyedeh Zahra Dehghanian, Liang-Yi Hung, Shiang-Jie Yang, Dao-Peng Chen, L. Jeffrey Medeiros, Jung-Hsien Chiang, Kung-Chao Chang
  Biomarker Research.2021;[Epub]     CrossRef
• The contributory roles of histone deacetylases (HDACs) in hematopoiesis regulation and possibilities for pharmacologic interventions in hematologic malignancies
  Mahdieh Mehrpouri, Atieh Pourbagheri-Sigaroodi, Davood Bashash
  International Immunopharmacology.2021; 100: 108114.     CrossRef
• Emerging role of histone deacetylase inhibitors in the treatment of diffuse large B-cell lymphoma
  Mingyang Wang, Xiaosheng Fang, Xin Wang
  Leukemia & Lymphoma.2020; 61(4): 763.     CrossRef

• Effective Treatment with PD-1 Antibody, Chidamide, Etoposide, and Thalidomide (PCET) for Relapsed/Refractory Natural Killer/T-Cell Lymphoma: A Report of Three Cases

  
  Lijun Du, Lei Zhang, Ling Li, Xin Li, Jiaqin Yan, Xinhua Wang, Xiaorui Fu, Zhenchang Sun, Xudong Zhang, Zhaoming Li, Jingjing Wu, Hui Yu, Yu Chang, Zhiyuan Zhou, Feifei Nan, Xiaolong Wu, Li Tian, Mingzhi Zhang
  OncoTargets and Therapy.2020; Volume 13: 7189.     CrossRef
• Overexpressed histone acetyltransferase 1 regulates cancer immunity by increasing programmed death-ligand 1 expression in pancreatic cancer
  Ping Fan, Jingyuan Zhao, Zibo Meng, Heyu Wu, Bo Wang, Heshui Wu, Xin Jin
  Journal of Experimental & Clinical Cancer Research.2019;[Epub]     CrossRef
• Histone modifications: A review about the presence of this epigenetic phenomenon in carcinogenesis
  Emanuely Silva Chrun, Filipe Modolo, Filipe Ivan Daniel
  Pathology - Research and Practice.2017; 213(11): 1329.     CrossRef
• Histone Acetyltransferase 1 Promotes Cell Proliferation and Induces Cisplatin Resistance in Hepatocellular Carcinoma
  Xin Jin, Shenghua Tian, Pingping Li
  Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics.2017; 25(6): 939.     CrossRef
• HDACs and HDAC Inhibitors in Cancer Development and Therapy
  Yixuan Li, Edward Seto
  Cold Spring Harbor Perspectives in Medicine.2016; 6(10): a026831.     CrossRef
• Histone deacetylase inhibitors and epigenetic regulation in lymphoid malignancies
  Diana Markozashvili, Vincent Ribrag, Yegor S. Vassetzky
  Investigational New Drugs.2015; 33(6): 1280.     CrossRef
• Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
  Hervé Ghesquieres, Susan L. Slager, Fabrice Jardin, Amelie S. Veron, Yan W. Asmann, Matthew J. Maurer, Thierry Fest, Thomas M. Habermann, Marie C. Bene, Anne J. Novak, Sylvain Mareschal, Corinne Haioun, Thierry Lamy, Stephen M. Ansell, Herve Tilly, Thomas
  Journal of Clinical Oncology.2015; 33(33): 3930.     CrossRef
• Histone deacetylase 2 controls p53 and is a critical factor in tumorigenesis
  Tobias Wagner, Peter Brand, Thorsten Heinzel, Oliver H. Krämer
  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2014; 1846(2): 524.     CrossRef
• Targetome profiling and functional genetics implicate miR-618 in lymphomagenesis
  Alan Fu, Aaron E Hoffman, Ran Liu, Daniel I Jacobs, Tongzhang Zheng, Yong Zhu
  Epigenetics.2014; 9(5): 730.     CrossRef
• Expression of Histone Deacetylases HDAC1, HDAC2, HDAC3, and HDAC6 in Invasive Ductal Carcinomas of the Breast
  Jinwon Seo, Soo Kee Min, Hye-Rim Park, Dong Hoon Kim, Mi Jung Kwon, Lee Su Kim, Young-Su Ju
  Journal of Breast Cancer.2014; 17(4): 323.     CrossRef
• Diffuse large B-cell lymphoma
  Maurizio Martelli, Andrés J.M. Ferreri, Claudio Agostinelli, Alice Di Rocco, Michael Pfreundschuh, Stefano A. Pileri
  Critical Reviews in Oncology/Hematology.2013; 87(2): 146.     CrossRef
• Histone deacetylase inhibitors activate CIITA and MHC class II antigen expression in diffuse large B‐cell lymphoma
  Kelly A. Cycon, Kathleen Mulvaney, Lisa M. Rimsza, Daniel Persky, Shawn P. Murphy
  Immunology.2013; 140(2): 259.     CrossRef

Citations

Citations to this article as recorded by  

• Stabilization of MOF (KAT8) by USP10 promotes esophageal squamous cell carcinoma proliferation and metastasis through epigenetic activation of ANXA2/Wnt signaling
  Peichao Li, Lingxiao Yang, Sun Young Park, Fanrong Liu, Alex H. Li, Yilin Zhu, Huacong Sui, Fengyuan Gao, Lingbing Li, Lan Ye, Yongxin Zou, Zhongxian Tian, Yunpeng Zhao, Max Costa, Hong Sun, Xiaogang Zhao
  Oncogene.2024; 43(12): 899.     CrossRef
• The Biological Significance of Targeting Acetylation-Mediated Gene Regulation for Designing New Mechanistic Tools and Potential Therapeutics
  Chenise O’Garro, Loveth Igbineweka, Zonaira Ali, Mihaly Mezei, Shiraz Mujtaba
  Biomolecules.2021; 11(3): 455.     CrossRef
• Histone Acetyltransferase MOF Orchestrates Outcomes at the Crossroad of Oncogenesis, DNA Damage Response, Proliferation, and Stem Cell Development
  Mayank Singh, Albino Bacolla, Shilpi Chaudhary, Clayton R. Hunt, Shruti Pandita, Ravi Chauhan, Ashna Gupta, John A. Tainer, Tej K. Pandita
  Molecular and Cellular Biology.2020;[Epub]     CrossRef
• The Functional Analysis of Histone Acetyltransferase MOF in Tumorigenesis
  Jiaming Su, Fei Wang, Yong Cai, Jingji Jin
  International Journal of Molecular Sciences.2016; 17(1): 99.     CrossRef
• Expression of hMOF, but not HDAC4, is responsible for the global histone H4K16 acetylation in gastric carcinoma
  LIN ZHU, JIAXING YANG, LINHONG ZHAO, XUE YU, LINGYAO WANG, FEI WANG, YONG CAI, JINGJI JIN
  International Journal of Oncology.2015; 46(6): 2535.     CrossRef
• Arsenic Trioxide Reduces Global Histone H4 Acetylation at Lysine 16 through Direct Binding to Histone Acetyltransferase hMOF in Human Cells
  Da Liu, Donglu Wu, Linhong Zhao, Yang Yang, Jian Ding, Liguo Dong, Lianghai Hu, Fei Wang, Xiaoming Zhao, Yong Cai, Jingji Jin, Tim Thomas
  PLOS ONE.2015; 10(10): e0141014.     CrossRef
• The histone acetyltransferase hMOF suppresses hepatocellular carcinoma growth
  Jin Zhang, Hui Liu, Hao Pan, Yuan Yang, Gang Huang, Yun Yang, Wei-Ping Zhou, Ze-Ya Pan
  Biochemical and Biophysical Research Communications.2014; 452(3): 575.     CrossRef
• Regulation and function of histone acetyltransferase MOF
  Yang Yang, Xiaofei Han, Jingyun Guan, Xiangzhi Li
  Frontiers of Medicine.2014; 8(1): 79.     CrossRef
• The histone acetylranseferase hMOF acetylates Nrf2 and regulates anti‐drug responses in human non‐small cell lung cancer
  Zhiwei Chen, Xiangyun Ye, Naiwang Tang, Shengping Shen, Ziming Li, Xiaomin Niu, Shun Lu, Ling Xu
  British Journal of Pharmacology.2014; 171(13): 3196.     CrossRef
• Correlation of low expression of hMOF with clinicopathological features of colorectal carcinoma, gastric cancer and renal cell carcinoma
  LINGLING CAO, LIN ZHU, JIAXING YANG, JIAMING SU, JINSONG NI, YUJUN DU, DA LIU, YANFANG WANG, FEI WANG, JINGJI JIN, YONG CAI
  International Journal of Oncology.2014; 44(4): 1207.     CrossRef
• Coactivator MYST1 Regulates Nuclear Factor-κB and Androgen Receptor Functions During Proliferation of Prostate Cancer Cells
  Anbalagan Jaganathan, Pratima Chaurasia, Guang-Qian Xiao, Marc Philizaire, Xiang Lv, Shen Yao, Kerry L. Burnstein, De-Pei Liu, Alice C. Levine, Shiraz Mujtaba
  Molecular Endocrinology.2014; 28(6): 872.     CrossRef
• A potential diagnostic marker for ovarian cancer: Involvement of the histone acetyltransferase, human males absent on the first
  NING LIU, RUI ZHANG, XIAOMING ZHAO, JIAMING SU, XIAOLEI BIAN, JINSONG NI, YING YUE, YONG CAI, JINGJI JIN
  Oncology Letters.2013; 6(2): 393.     CrossRef
• Epigenetic change in kidney tumor: downregulation of histone acetyltransferase MYST1 in human renal cell carcinoma
  Yong Wang, Rui Zhang, Donglu Wu, Zhihua Lu, Wentao Sun, Yong Cai, Chunxi Wang, Jingji Jin
  Journal of Experimental & Clinical Cancer Research.2013;[Epub]     CrossRef